PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.13%
Net income growth at 50-75% of MRVL's 21.67%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-0.48%
Negative yoy D&A while MRVL is 1.08%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
100.00%
Deferred tax of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-100.00%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-17952.38%
Negative yoy working capital usage while MRVL is 101.39%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-100.00%
AR is negative yoy while MRVL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-12.31%
Both reduce yoy inventory, with MRVL at -106.14%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-7148.17%
Negative yoy usage while MRVL is 103.07%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
526.92%
Growth of 526.92% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
-47.14%
Negative yoy CFO while MRVL is 62.73%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-116.12%
Both yoy lines negative, with MRVL at -5.71%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-36.15%
Both yoy lines negative, with MRVL at -55.53%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-22.96%
Both yoy lines are negative, with MRVL at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-1107.50%
Both yoy lines negative, with MRVL at -2.33%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while MRVL is 56.50%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.25%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.